Table 4a.
Demographic and comorbidity data in non fibrotic and fibrotic group.
| No Fibrosis | Post-COVID Fibrosis | P value (no. of observations) | OR (95% CI) unadjusted | OR (95% CI) adjusted | |
|---|---|---|---|---|---|
| Agea | 63 (50–76) | 61.5 (54.5–66.5) | ns (387) | ||
| Sex (male) | 191 (54.4%) | 28 (77.8%) | p = 0.007* (387) | 2.93 (1.3–6.6) | 1.61 (0.58–4.47)b |
| Chronic lung disease | 67 (19.3%) | 7 (19.4%) | ns (383) | ||
| COPD | 13 (3.7%) | 1 (2.8%) | ns (383) | ||
| Asthma | 28 (8%) | 4 (11.1%) | ns (383) | ||
| Diabetes mellitus | 95 (27.1%) | 6 (16.7%) | ns (386) | ||
| Hypertension | 131 (37.5%) | 13 (36%) | ns (385) | ||
| Ischemic heart disease | 40 (11.4%) | 1 (2.8%) | ns (386) | ||
| Chronic liver disease | 4 (1.2%) | 0 (0%) | ns (385) | ||
| Chronic Dialysis | 15 (4.3%) | 0 (0%) | ns (387) | ||
| Smokers | 226 (68.3%) | 25(73.5%) | ns (383) | ||
| BMIa | 27.4 (23.7–31.7) | 26.4 (23.4–30.3) | ns (337) | ||
| Ethnic - White | 114 (38.8%) | 10 (34.5%) | ns (323) | ||
| Ethic - Black | 62 (21.1%) | 6 (20.7%) | ns (323) | ||
| Ethnic -Asian | 54 (18.4%) | 7 (24.1%) | ns (323) | ||
| Ethnic - other | 64 (21.8%) | 6 (20.7%) | ns (323) |
Data presented as Frequency (%) compared using Chi square test except.
a
Median (interquartile range) compared using Mann-Whitney U test * significant.
b
Adjusted for male sex, persistent breathlessness, myalgia, invasive ventilation, Peak WBC count and high risk CXR during COVID-19 admission.